FIZE Medical Achieves CE Mark and UKCA Certification, Expands Operations in Europe and UK

FIZE Medical Expands Its Global Presence

JERICHO, N.Y., July 27, 2026 — FIZE Medical, a pioneering company focused on revolutionizing fluid management in critical care, proudly announces its recent achievement of CE Mark and UKCA certification for its innovative FIZE kUO® System. This important regulatory milestone positions the company to commence comprehensive commercial operations across Europe and the UK, significantly bolstering its international footprint.

With CE Mark and UKCA certification secured, FIZE Medical can now successfully penetrate key healthcare markets in Europe and the UK, complementing its established presence in both North America and Japan. Dror Zerem, CEO of FIZE Medical, expressed his enthusiasm by stating, "Receiving the CE Mark and UKCA Certification is a pivotal milestone for FIZE Medical. It validates the safety, performance, and clinical value of our technology and marks an important step in bringing our solution to hospitals in the EU and the UK."

The FIZE kUO® System is designed to facilitate precision fluid management through continuous and real-time digital monitoring. This enhances clinical interventions while positively affecting patient outcomes in intensive care situations. By using this advanced monitoring system, healthcare professionals can take timely actions that can be lifesaving for critically ill patients.

To ensure successful market integration, FIZE Medical has formed strategic alliances with prominent medical device distributors across various European nations. This will foster efficient distribution channels for their product while ensuring that local healthcare teams can seamlessly adopt the technology. The company is also keen on providing a localized experience, having customized the platform for initial launch countries by offering user-friendly interfaces in native languages.

By establishing its commercial infrastructure and leveraging these partnerships, FIZE Medical stands ready to enhance patient care across numerous hospitals in Europe and the UK. Zerem continued, "We look forward to partnering with hospitals across Europe and the UK to equip intensive care teams with continuous, real-time digital monitoring that supports precision fluid management, earlier clinical intervention, and better patient outcomes."

FIZE Medical is not just about market expansion; it signifies a commitment to advancing healthcare technologies that effectively address urgent medical needs. The company’s focus on continuous innovation and the use of AI-driven data insights aims to redefine how fluid management is approached in critical care environments. Through evidence-based practices, FIZE Medical is dedicated to improving patient recovery times and enhancing overall care standards.

To discover more about FIZE Medical and its strategic initiatives for global commercialization, interested parties can visit their official website at fizemedical.com.

As the healthcare landscape continues to evolve, advancements like those made by FIZE Medical are crucial for maintaining high standards of patient care and safety in critical situations. Their commitment to providing innovative medical solutions is sure to yield significant benefits for healthcare systems around the world, particularly for critically ill patients in need of effective fluid management solutions.